Association between physical activity and risk of bleeding in children with hemophilia
- PMID: 23047359
- DOI: 10.1001/jama.2012.12727
Association between physical activity and risk of bleeding in children with hemophilia
Abstract
Context: Vigorous physical activity is thought to increase risk of bleeds in children with hemophilia, but the magnitude of the risk is unknown.
Objective: To quantify the transient increase in risk of bleeds associated with physical activity in children with hemophilia.
Design, setting, and participants: A case-crossover study nested within a prospective cohort study was conducted at 3 pediatric hemophilia centers in Australia between July 2008 and October 2010. A total of 104 children and adolescent boys aged 4 through 18 years with moderate or severe hemophilia A or B were monitored for bleeds for up to 1 year. Following each bleed, the child or parent was interviewed to ascertain exposures to physical activity preceding the bleed. Physical activity was categorized according to expected frequency and severity of collisions. The risk of bleeds associated with physical activity was estimated by contrasting exposure to physical activity in the 8 hours before the bleed with exposures in two 8-hour control windows, controlling for levels of clotting factor in the blood.
Main outcome measures: Association of physical activity and factor level with risk of bleeding.
Results: The participants were observed for 4839 person-weeks during which time 436 bleeds occurred. Of these, 336 bleeds occurred more than 2 weeks after the preceding bleed and were used in the primary analysis of risk. Compared with inactivity and category 1 activities (eg, swimming), category 2 activities (eg, basketball) were associated with a transient increase in the risk of bleeding (30.6% of bleed windows vs 24.8% of first control windows; odds ratio, 2.7; 95% CI, 1.7-4.8, P < .001). Category 3 activities (eg, wrestling) were associated with a greater transient increase in risk (7.0% of bleed windows vs 3.4% of first control windows; odds ratio, 3.7; 95% CI, 2.3-7.3, P < .001). To illustrate absolute risk increase, for a child who bleeds 5 times annually and is exposed on average to category 2 activities twice weekly and to category 3 activities once weekly, exposure to these activities was associated with only 1 of the 5 annual bleeds. For every 1% increase in clotting factor level, bleeding incidence was lower by 2% (95% CI, 1%-3%; P = .004).
Conclusions: In children and adolescents with hemophilia, vigorous physical activity was transiently associated with a moderate relative increase in risk of bleeding. Because the increased relative risk is transient, the absolute increase in risk of bleeds associated with physical activity is likely to be small.
Comment in
-
Collision sports and risk of bleeding in children with hemophilia.JAMA. 2012 Oct 10;308(14):1480-1. doi: 10.1001/jama.2012.13303. JAMA. 2012. PMID: 23047364 No abstract available.
Similar articles
-
Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or B.Cochrane Database Syst Rev. 2005 Apr 18;(2):CD003429. doi: 10.1002/14651858.CD003429.pub2. Cochrane Database Syst Rev. 2005. Update in: Cochrane Database Syst Rev. 2006 Apr 19;(2):CD003429. doi: 10.1002/14651858.CD003429.pub3 PMID: 15846666 Updated. Review.
-
Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or B.Cochrane Database Syst Rev. 2006 Apr 19;(2):CD003429. doi: 10.1002/14651858.CD003429.pub3. Cochrane Database Syst Rev. 2006. Update in: Cochrane Database Syst Rev. 2011 Sep 07;(9):CD003429. doi: 10.1002/14651858.CD003429.pub4 PMID: 16625581 Updated. Review.
-
Hemophilia with factor VIII and factor IX inhibitors, incidence, bleeding problems and management.Southeast Asian J Trop Med Public Health. 1993;24 Suppl 1:106-12. Southeast Asian J Trop Med Public Health. 1993. PMID: 7886549
-
Home treatment of mild to moderate bleeding episodes using recombinant factor VIIa (Novoseven) in haemophiliacs with inhibitors.Thromb Haemost. 1998 Dec;80(6):912-8. Thromb Haemost. 1998. PMID: 9869160 Clinical Trial.
-
Comparing bleed frequency and factor concentrate use between haemophilia A and B patients.Haemophilia. 2011 Nov;17(6):872-4. doi: 10.1111/j.1365-2516.2011.02506.x. Epub 2011 Feb 22. Haemophilia. 2011. PMID: 21342368
Cited by
-
Anesthetic considerations for joint replacement surgery in hemophilic arthropathy: a comprehensive review.Anesth Pain Med (Seoul). 2024 Jul;19(3):194-208. doi: 10.17085/apm.24047. Epub 2024 Jul 23. Anesth Pain Med (Seoul). 2024. PMID: 39069647 Free PMC article. Review.
-
Physical Activity, Bleedings and Quality of Life in Subjects with Haemophilia A without Inhibitors-A Multicenter, Observational Italian Study with a Wearable Device.J Clin Med. 2024 May 22;13(11):3036. doi: 10.3390/jcm13113036. J Clin Med. 2024. PMID: 38892747 Free PMC article.
-
Current Status and Challenges in Delivering Comprehensive Care for Patients with Hemophilia.J Blood Med. 2023 Dec 15;14:629-637. doi: 10.2147/JBM.S446204. eCollection 2023. J Blood Med. 2023. PMID: 38125786 Free PMC article. Review.
-
Association of physical activity with bleeding events and safety in patients with haemophilia A starting emicizumab prophylaxis: an interim analysis of the TSUBASA study.Int J Hematol. 2024 Jan;119(1):14-23. doi: 10.1007/s12185-023-03679-8. Epub 2023 Dec 15. Int J Hematol. 2024. PMID: 38100026 Free PMC article.
-
Minimum factor VIII levels to prevent joint bleeding in mild hemophilia A.Blood Adv. 2023 Dec 12;7(23):7209-7215. doi: 10.1182/bloodadvances.2023011366. Blood Adv. 2023. PMID: 37871302 Free PMC article.
